Publicacións en colaboración con investigadores/as de University of Leicester (9)

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

2022

  1. Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

    Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520

2021

  1. Empagliflozin in heart failure with a preserved ejection fraction

    New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461

2020

  1. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” (Pancreatology (2018) 18(8) (847–854), (S1424390318306938), (10.1016/j.pan.2018.09.016))

    Pancreatology

2018

  1. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis

    Pancreatology, Vol. 18, Núm. 8, pp. 847-854

2016

  1. Distinct phosphorylation sites on the ghrelin receptor, GHSR1a, establish a code that determines the functions of ß-arrestins

    Scientific Reports, Vol. 6

  2. Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: The AFFIRM study

    Annals of Oncology, Vol. 27, Núm. 7, pp. 1273-1279

  3. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis

    QJM, Vol. 109, Núm. 6, pp. 377-382

2005

  1. Migration and mental health in Europe (The state of the mental health in Europe working group: Appendix I)

    Clinical Practice and Epidemiology in Mental Health, Vol. 1